News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Valeant Pharmaceuticals International
NEWS
IN THE PRESS
NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Policy
“Charged With A Crime For Doing His Job": Valeant Duo Fights Back
November 18, 2016
·
1 min read
Genetown
Valeant Used One Simple Strategy To Get Insurers To Pay For A $1,000 Drug With $100 Alternatives
November 10, 2016
·
1 min read
Pharm Country
Why Valeant Can’t “Dig Out Of That Hole” Fast Enough
November 9, 2016
·
1 min read
Deals
Valeant’s Many Acquisitions Led to Manufacturing Issues, Says the FDA
November 9, 2016
·
1 min read
Deals
Cash-Strapped Valeant in Talks to Divest Salix to Takeda for as Much as $10 Billion
November 1, 2016
·
2 min read
Policy
Former Valeant CEO and CFO May Face Criminal Charges
November 1, 2016
·
3 min read
Valeant Raises List Prices Of Some Products By Up To 9%
October 17, 2016
·
1 min read
Policy
Anger Behind the Scenes When Valeant Jacked Up Price by 2,700% for Lead Poisoning Drug
October 12, 2016
·
2 min read
Deals
Valeant Slaps ‘For Sale’ Sign on iNova Pharma, Deal Could Bring in $1 Billion+
September 23, 2016
·
2 min read
IN THE PRESS
Business
Valeant Announces 2017 Annual Meeting Of Shareholders Webcast And Q1 2017 Financial Results Conference Call
April 11, 2017
·
2 min read
Valeant Completes Refinancing Transactions
March 22, 2017
·
2 min read
Valeant Announces The Early Results Of Tender Offers For Its 6.75% Senior Notes Due 2018
March 21, 2017
·
5 min read
Business
Glycyx PharmaVentures And Valeant Agree To Binding Terms Of Licensing Agreement In The Field Of Oncology
March 16, 2017
·
2 min read
Valeant Receives Lender Consent For Refinancing And Amendment Of Credit Agreement
March 13, 2017
·
2 min read
Valeant Announces Upsizing Of Cash Tender Offer For Its 6.75% Senior Notes Due 2018
March 10, 2017
·
7 min read
Valeant Announces Launch Of Private Offering Of Senior Secured Notes
March 9, 2017
·
4 min read
Valeant Commences Cash Tender Offer For Up To $600,000,000 Outstanding Principal Amount Of Its 6.75% Senior Notes Due 2018
March 8, 2017
·
7 min read
Valeant Completes Approximately $1.1 Billion Pay Down Of Senior Secured Term Loans From Divestitures; To Seek Refinancing And Amendment Of Credit Agreement
March 6, 2017
·
4 min read
Deals
Valeant Completes Sale Of CeraVe, AcneFree And AMBI Skincare Brands To L’Oréal
March 3, 2017
·
2 min read